Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
N

NHI

NYSE

NATIONAL HEALTH INVESTORS INC

Latest disclosureJuly 30, 2026
Insider score Why 14?
14/ 100
Qualifying buys · 30d
$0

2 purchases · 0 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 9

Limited filing history
All9Buying2Selling0Other7
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

7 of 9 trades · March 3, 2026 – July 27, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 7 trades on this page.

Award disclosed

Christian Ken Maingot

Chief Operating Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded July 27, 2026Filed July 30, 2026SEC filing
Gift disclosed

James R. Jobe

Director

Common Stock

Value context
Not a purchase
Reported price
Gift · no purchase price
Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Traded June 5, 2026Filed June 9, 2026SEC filing
Tax or exercise withholding

John L. Spaid

CFO/EVP Finance

Common Stock

Value context
$22.95K
Reported price
$73.09 / share
Traded May 5, 2026Filed May 7, 2026SEC filing
Tax or exercise withholding

D. Eric Mendelsohn

CEO and President

Common Stock

Value context
$28.8K
Reported price
$73.09 / share
Traded May 5, 2026Filed May 7, 2026SEC filing
Tax or exercise withholding

David L. Travis

SVP/Chief Accounting Officer

Common Stock

Value context
$20.61K
Reported price
$73.09 / share
Traded May 5, 2026Filed May 7, 2026SEC filing
Award disclosedAmended filing

Kevin Carlton Pascoe

Chief Investment Officer

Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit
$0.00
Raw implied value
$0.00
Verified price
—
Verified value
—
Confidence
low
Validation findings
amendment requires reconciliation
Original transaction filing ↗

Common Stock

Value context
—
Reported price
—
Understand this price

Filing error, value unverified. The filed amounts are preserved for review and excluded from buying signals and transaction totals until verified.

Traded March 3, 2026Filed March 30, 2026SEC filing
Award disclosedAmended filing

John L. Spaid

CFO/EVP Finance

Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit
$0.00
Raw implied value
$0.00
Verified price
—
Verified value
—
Confidence
low
Validation findings
amendment requires reconciliation
Original transaction filing ↗

Common Stock

Value context
—
Reported price
—
Understand this price

Filing error, value unverified. The filed amounts are preserved for review and excluded from buying signals and transaction totals until verified.

Traded March 3, 2026Filed March 30, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Operating OfficerCommon StockGrant or award2,370Award · no purchase priceNon-cash awardJul 27Filed Jul 30 · 3d laterSEC filing
DirectorCommon StockGift225Gift · no purchase priceNot a purchaseJun 5Filed Jun 9 · 4d laterSEC filing
CFO/EVP FinanceCommon StockExercise-price or tax withholding314$73.09 / share$22.95KMay 5Filed May 7 · 2d laterSEC filing
CEO and PresidentCommon StockExercise-price or tax withholding394$73.09 / share$28.8KMay 5Filed May 7 · 2d laterSEC filing
SVP/Chief Accounting OfficerCommon StockExercise-price or tax withholding282$73.09 / share$20.61KMay 5Filed May 7 · 2d laterSEC filing
Chief Investment Officer
Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit
$0.00
Raw implied value
$0.00
Verified price
—
Verified value
—
Confidence
low
Validation findings
amendment requires reconciliation
Original transaction filing ↗
Common StockGrant or award4,726——Mar 3Filed Mar 30 · 27d laterSEC filing
CFO/EVP Finance
Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit
$0.00
Raw implied value
$0.00
Verified price
—
Verified value
—
Confidence
low
Validation findings
amendment requires reconciliation
Original transaction filing ↗
Common StockGrant or award5,072——Mar 3Filed Mar 30 · 27d laterSEC filing
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$41,757 of common-equity purchase value after transaction-age decay across 180 days.

+6 pts

Distinct buying groups

2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+4 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+4 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source
SEC EDGAR · Form 4
Issuer CIK
0000877860
Latest public acceptance
Jul 30, 2026, 07:08 PM UTC
Score calculated
Oct 8, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Congress transactions 2

All Congress filings
Purchase disclosed

National Health Investors, Inc. Common Stock (NHI) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
July 10, 2026
Filed September 4, 2026 · 56d laterOriginal report
Purchase disclosed

National Health Investors, Inc. Common Stock (NHI) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 15, 2026
Filed February 13, 2026 · 29d laterOriginal report